These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8593385)

  • 1. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
    Campbell IA
    Tuber Lung Dis; 1995 Dec; 76(6):583. PubMed ID: 8593385
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
    Sauret J; Hernández-Flix S; Castro E; Hernández L; Ausina V; Coll P
    Tuber Lung Dis; 1995 Apr; 76(2):104-8. PubMed ID: 7780090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis due to Mycobacterium kansasii.
    Elder JL; Edwards FG; Abrahams EW
    Aust N Z J Med; 1977 Feb; 7(1):8-13. PubMed ID: 266899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of disease due to Mycobacterium kansasii.
    Griffith DE
    Clin Chest Med; 2002 Sep; 23(3):613-21, vi. PubMed ID: 12370997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
    Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
    Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
    Santin M; Dorca J; Alcaide F; Gonzalez L; Casas S; Lopez M; Guerra MR
    Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary Mycobacterium fortuitum infection with multiple nodular shadows in a healthy man].
    Inoue T; Tanaka E; Sakuramoto M; Maeda Y; Maniwa K; Taguchi Y
    Kekkaku; 2004 Oct; 79(10):573-7. PubMed ID: 15631109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary disease due to Mycobacterium terrae.
    Palmero DJ; Teres RI; Eiguchi K
    Tubercle; 1989 Dec; 70(4):301-3. PubMed ID: 2626806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal mycobacterial infection in a 32-year-old man with AIDS.
    Whitson BD; George RB
    Chest; 1994 Nov; 106(5):1577-9. PubMed ID: 7956422
    [No Abstract]   [Full Text] [Related]  

  • 13. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs.
    Ahn CH; Lowell JR; Ahn SS; Ahn S; Hurst GA
    Rev Infect Dis; 1981; 3(5):1028-34. PubMed ID: 7339800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present status of chemotherapy for tuberculosis.
    Grosset JH
    Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of medical treatment in Mycobacterium intracellulare infection.
    Dutt AK; Stead WW
    Am J Med; 1979 Sep; 67(3):449-53. PubMed ID: 474589
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycobacterium kansasii olecranon bursitis.
    Barham GS; Hargreaves DG
    J Med Microbiol; 2006 Dec; 55(Pt 12):1745-1746. PubMed ID: 17108281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy in combination with the rapid intravenous administration of isoniazid in pulmonary tuberculosis].
    Zbants AN; Tsurkan VP; Mustiatsé NA; Kurochkin SIa; Ustiian AI
    Probl Tuberk; 1982 Dec; (12):45-8. PubMed ID: 7156122
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis.
    Bai KJ; Yu MC; Suo J; Chiang CY; Chiang IH; Lin TP; Luh KT
    J Formos Med Assoc; 1998 Apr; 97(4):278-82. PubMed ID: 9585680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.